Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy
出版年份 2020 全文链接
标题
Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy
作者
关键词
-
出版物
Drug Design Development and Therapy
Volume Volume 14, Issue -, Pages 2623-2636
出版商
Informa UK Limited
发表日期
2020-07-06
DOI
10.2147/dddt.s224771
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides
- (2020) Anna Wolska et al. Science Translational Medicine
- Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia
- (2020) PadmaKumar Narayanan et al. Nucleic Acid Therapeutics
- Apolipoprotein C-II
- (2020) Anna Wolska et al. CURRENT OPINION IN LIPIDOLOGY
- The Chylomicronemia Syndrome Is Most Often Multifactorial
- (2019) Alan Chait et al. ANNALS OF INTERNAL MEDICINE
- N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
- (2019) Veronica J Alexander et al. EUROPEAN HEART JOURNAL
- Metabolism and Disposition of Volanesorsen, a 2′ MOE Antisense Oligonucleotide, Across Species
- (2019) Noah Post et al. DRUG METABOLISM AND DISPOSITION
- Volanesorsen: First Global Approval
- (2019) Julia Paik et al. DRUGS
- Intestinal basolateral lipid substrate transport (BLST) is linked to chylomicron secretion and is regulated by apoC-III.
- (2019) Diana Li et al. JOURNAL OF LIPID RESEARCH
- Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
- (2019) Jenny E. Kanter et al. JOURNAL OF CLINICAL INVESTIGATION
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- A NEW DAWN FOR MANAGING DYSLIPIDEMIAS: THE ERA OF RNA-BASED THERAPIES
- (2019) C. Macchi et al. PHARMACOLOGICAL RESEARCH
- Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes
- (2019) Laura D’Erasmo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome
- (2018) Victoria Marco-Benedí et al. ATHEROSCLEROSIS
- Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”
- (2018) Philippe Moulin et al. ATHEROSCLEROSIS
- Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3
- (2018) Alexandra C. Chadwick et al. CIRCULATION
- Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism
- (2018) Bastian Ramms et al. CURRENT OPINION IN LIPIDOLOGY
- The Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Lipid Metabolism, Glucose Homeostasis and Inflammation
- (2018) Virginia Actis Dato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS †
- (2018) Andres Gelrud et al. Journal of Clinical Lipidology
- Roundtable on etiology of familial chylomicronemia syndrome
- (2018) William Virgil Brown et al. Journal of Clinical Lipidology
- Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study
- (2018) Dirk J. Blom et al. Journal of Clinical Lipidology
- Clinical and biochemical features of different molecular etiologies of familial chylomicronemia
- (2018) Robert A. Hegele et al. Journal of Clinical Lipidology
- The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study
- (2018) Michael Davidson et al. Journal of Clinical Lipidology
- Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome
- (2018) Rabia Chaudhry et al. Expert Review of Clinical Pharmacology
- A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities
- (2018) Basak Ozgen Saydam et al. ENDOCRINE RESEARCH
- Extreme Hypertriglyceridemia: genetic diversity, pancreatitis, pregnancy, and prevalence
- (2018) Vadzim Chyzhyk et al. Journal of Clinical Lipidology
- Management of Hypertriglyceridemia Induced Acute Pancreatitis
- (2018) Rajat Garg et al. Biomed Research International
- Severe hypertriglyceridemia is primarily polygenic
- (2018) Jacqueline S. Dron et al. Journal of Clinical Lipidology
- Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease
- (2018) Iram Hussain et al. PATHOLOGY
- Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials
- (2018) Amirhossein Sahebkar et al. BMJ Open
- Clinical Profile and Natural Course in a Large Cohort of Patients With Hypertriglyceridemia and Pancreatitis
- (2017) Kishore Vipperla et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL
- (2017) Mikael Larsson et al. JOURNAL OF LIPID RESEARCH
- Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
- (2017) Jan Oscarsson et al. Lipids in Health and Disease
- A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
- (2017) Sumeet A Khetarpal et al. NATURE MEDICINE
- Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia
- (2017) Anne P. Beigneux et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
- (2017) Mark J. Graham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction of refractory thrombocytopenia and anemia following withdrawal of extended release niacin
- (2016) Casey O'Connell et al. AMERICAN JOURNAL OF HEMATOLOGY
- Targeted exonic sequencing of GWAS loci in the high extremes of the plasma lipids distribution
- (2016) Aniruddh P. Patel et al. ATHEROSCLEROSIS
- Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics
- (2016) Josep Julve et al. CLINICA CHIMICA ACTA
- Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
- (2016) Andres Digenio et al. DIABETES CARE
- Lipodystrophy Syndromes
- (2016) Iram Hussain et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Anti-sense oligonucleotide therapies for the treatment of hyperlipidaemia
- (2016) Anthony S. Wierzbicki et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis
- (2016) Daniel Gaudet et al. HUMAN GENE THERAPY
- The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline
- (2016) Rebecca J. Brown et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- JCL roundtable: Diagnosis and clinical management of lipodystrophy
- (2016) William Virgil Brown et al. Journal of Clinical Lipidology
- Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system
- (2016) Nazia Rashid et al. Journal of Clinical Lipidology
- Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism
- (2016) Ilenia Minicocci et al. JOURNAL OF LIPID RESEARCH
- The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking
- (2016) Ren Zhang Open Biology
- Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis
- (2016) Simon B. Pedersen et al. JAMA Internal Medicine
- Intestinal scavenger receptor class B type I as a novel regulator of chylomicron production in healthy and diet-induced obese states
- (2015) Marsel Lino et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effects of Extended-Release Niacin on the Postprandial Metabolism of Lp(a) and ApoB-100–Containing Lipoproteins in Statin-Treated Men With Type 2 Diabetes MellitusSignificance
- (2015) Esther M. Ooi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of niacin and omega-3 fatty acids on the apolipoproteins in overweight patients with elevated triglycerides and reduced HDL cholesterol
- (2015) Olga V. Savinova et al. ATHEROSCLEROSIS
- In vivo evidence for chylomicrons as mediators of postprandial inflammation
- (2015) Marijke A. de Vries et al. ATHEROSCLEROSIS
- Treatment of primary hypertriglyceridemia states – General approach and the role of extracorporeal methods
- (2015) Claudia Stefanutti et al. ATHEROSCLEROSIS SUPPLEMENTS
- The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
- (2015) Frank M. Sacks CURRENT OPINION IN LIPIDOLOGY
- Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
- (2015) Charles Daniel Meyers et al. Lipids in Health and Disease
- Glybera's Second Act: The Curtain Rises on the High Cost of Therapy
- (2015) Seppo Ylä-Herttuala MOLECULAR THERAPY
- $1-million price tag set for Glybera gene therapy
- (2015) Chris Morrison NATURE BIOTECHNOLOGY
- Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
- (2015) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of ω-3 Fatty Acid Ethyl Esters on Apolipoprotein B-48 Kinetics in Obese Subjects on a Weight-Loss Diet: A New Tracer Kinetic Study in the Postprandial State
- (2014) Annette T. Y. Wong et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1
- (2014) Zahid Ahmad et al. Journal of Clinical Lipidology
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- Severe Hypertriglyceridemia With Pancreatitis
- (2013) Frank M. Sacks et al. JAMA Internal Medicine
- Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
- (2012) D Gaudet et al. GENE THERAPY
- Lipid-Modifying Therapies and Risk of Pancreatitis
- (2012) David Preiss et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of Severe (500 to 2,000 mg/dl) Hypertriglyceridemia in United States Adults
- (2011) Jennifer B. Christian et al. AMERICAN JOURNAL OF CARDIOLOGY
- Apolipoprotein A-V; a potent triglyceride reducer
- (2011) Stefan K. Nilsson et al. ATHEROSCLEROSIS
- APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrate
- (2011) M. Guardiola et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency
- (2010) Daniel Gaudet et al. ATHEROSCLEROSIS SUPPLEMENTS
- Etiology and risk of lactescent plasma and severe hypertriglyceridemia
- (2010) Karine Tremblay et al. Journal of Clinical Lipidology
- Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins
- (2009) Carlos O. Mendivil et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Acute Pancreatitis in a Cohort of 129 Patients Referred for Severe Hypertriglyceridemia
- (2009) Célia Lloret Linares et al. PANCREAS
- Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia
- (2008) Jean-Charles Hogue et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started